Cargando…
Evaluating the activity of N-89 as an oral antimalarial drug
Despite the recent progress in public health measures, malaria remains a troublesome disease that needs to be eradicated. It is essential to develop new antimalarial medications that are reliable and secure. This report evaluated the pharmacokinetics and antimalarial activity of 1,2,6,7-tetraoxaspir...
Autores principales: | Aly, Nagwa S. M., Matsumori, Hiroaki, Dinh, Thi Quyen, Sato, Akira, Miyoshi, Shin-ichi, Chang, Kyung-Soo, Yu, Hak Sun, Kubota, Takaaki, Kurosaki, Yuji, Cao, Duc Tuan, Rashed, Gehan A., Kim, Hye-Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Parasitology and Tropical Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471475/ https://www.ncbi.nlm.nih.gov/pubmed/37648233 http://dx.doi.org/10.3347/PHD.23044 |
Ejemplares similares
-
Pioneer Use of Antimalarial Transdermal Combination Therapy in Rodent Malaria Model
por: Aly, Nagwa S. M., et al.
Publicado: (2023) -
Antimalarial effect of synthetic endoperoxide on synchronized Plasmodium chabaudi infected mice
por: Aly, Nagwa S. M., et al.
Publicado: (2023) -
Pharmacokinetic analysis of new synthetic antimalarial N-251
por: Okada, Kazuaki, et al.
Publicado: (2019) -
Diagnosis of Toxoplasmosis Using Surface Antigen Grade 1 Detection by ELISA, Nano-Gold ELISA, and PCR in Pregnant Women
por: Aly, Nagwa S M, et al.
Publicado: (2023) -
Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251
por: Ueda, Youki, et al.
Publicado: (2018)